Provider
Alternative Dosage Form - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Documents & Forms Results
Displaying 3771 - 3780 of 3863 results
Provider
Dry Eye Disease - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Provider
GLP-1 (glucagon-like peptide-1) Agonists - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Provider
DPP-4 Inhibitors and Combinations - Commercial
Step Therapy, Quantity Limit
Program effective Date: Oct 01, 2026
Provider
Constipation Agents - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026
Provider
Gabapentin ER (extended-release) [Horizant, Gralise] - Commercial
Step Therapy, Quantity Limit
Program effective Date: Oct 01, 2026
Provider
Familial Chylomicronemia Syndrome - Commercial
Prior Authorization, Quantity Limit
Program effective Date: Oct 01, 2026